ANDERSON KERRII B — SEC Form 4 filings
SEC reporting owner CIK 1227159. 47 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2024-01-09 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 13 filings — 29,792 shares, $6,181,072 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 44.
- Largest priced transaction: sale of 3,500 shares @ $280.00 ($980,000) in LABCORP HOLDINGS INC., filed 2025-07-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | Director | 15 | — | 12 legs · 15,000 sh · $4,095,436 | 9 |
| ABERCROMBIE & FITCH CO /DE/ (ANF) | Director | 14 | — | 7 legs · 14,792 sh · $2,085,636 | 17 |
| SHERWIN WILLIAMS CO (SHW) | Director | 14 | — | — | 14 |
| WORTHINGTON ENTERPRISES, INC. (WOR) | Director | 4 | — | — | 4 |
Form 4 filings — ANDERSON KERRII B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 3,000 @ $318.02 | EDGAR |
| 2026-08-04 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Grant/award (A): 91.04 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 28.54 @ $350.40 | EDGAR |
| 2026-06-05 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Option exercise (M): 1,567 @ $0 · Option exercise (M): 522 (derivative) @ $0 · Grant/award (A): 2,160 (derivative) @ $0 · Option exercise (M): 2,089 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Grant/award (A): 107.20 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 31.70 @ $315.50 | EDGAR |
| 2026-02-17 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 558 @ $0 | EDGAR |
| 2026-02-13 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 773 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Grant/award (A): 92.83 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 28.94 @ $345.60 | EDGAR |
| 2025-11-04 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Grant/award (A): 124.91 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 29.09 @ $343.81 | EDGAR |
| 2025-09-26 | 4 | WORTHINGTON ENTERPRISES, INC. (WOR) | Grant/award (A): 2,815 @ $0 | EDGAR |
| 2025-09-24 | 4 | WORTHINGTON ENTERPRISES, INC. (WOR) | Grant/award (A): 286.26 (derivative) @ $60.26 | EDGAR |
| 2025-09-03 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Sale (S): 4,292 @ $95.12 | EDGAR |
| 2025-08-05 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Grant/award (A): 99.52 (derivative) @ $0 | EDGAR |
| 2025-07-28 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 3,500 @ $280 | EDGAR |
| 2025-07-28 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 3,500 @ $280 | EDGAR |
| 2025-07-09 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 28.86 @ $346.53 | EDGAR |
| 2025-07-02 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 500 @ $265 | EDGAR |
| 2025-06-13 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Option exercise (M): 780 @ $0 · Grant/award (A): 2,089 (derivative) @ $0 · Option exercise (M): 780 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 500 @ $260 | EDGAR |
| 2025-05-07 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Grant/award (A): 128.02 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 29.56 @ $338.25 | EDGAR |
| 2025-03-07 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 500 @ $255.63 | EDGAR |
| 2025-02-20 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 517 @ $0 | EDGAR |
| 2025-02-13 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 897 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 944 · Option exercise (M): 944 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 1,000 @ $235 | EDGAR |
| 2025-01-07 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 29.85 @ $335 | EDGAR |
| 2024-12-04 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Gift (G): 2,000 @ $0 | EDGAR |
| 2024-10-25 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 1,000 @ $230 | EDGAR |
| 2024-10-08 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 26.85 @ $372.47 | EDGAR |
| 2024-09-30 | 4 | WORTHINGTON ENTERPRISES, INC. (WOR) | Grant/award (A): 563.31 (derivative) @ $40.83 | EDGAR |
| 2024-09-27 | 4 | WORTHINGTON ENTERPRISES, INC. (WOR) | Grant/award (A): 3,300 @ $0 | EDGAR |
| 2024-08-09 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 414 @ $225 · Sale (S): 586 @ $225 | EDGAR |
| 2024-07-09 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 33.84 @ $295.50 | EDGAR |
| 2024-06-14 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Grant/award (A): 780 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Option exercise (M): 4,292 @ $0 · Option exercise (M): 4,292 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Sale (S): 900 @ $171.67 · Sale (S): 1,100 @ $170.39 · Sale (S): 2,100 @ $173.92 · Sale (S): 3,400 @ $173.01 | EDGAR |
| 2024-05-02 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Sale (S): 250 @ $204.13 · Sale (S): 250 @ $200.10 | EDGAR |
| 2024-04-09 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 30.16 @ $331.56 | EDGAR |
| 2024-03-11 | 4 | ABERCROMBIE & FITCH CO /DE/ (ANF) | Sale (S): 230 @ $127.75 · Sale (S): 2,770 @ $127.30 | EDGAR |
| 2024-02-15 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 594 @ $0 | EDGAR |
| 2024-02-08 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 947 · Grant/award (A): 944 (derivative) @ $0 · Option exercise (M): 947 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | SHERWIN WILLIAMS CO (SHW) | Grant/award (A): 33.67 @ $296.96 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1227159 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →